Dashboard
Manage Tickers

CORCencora, Inc.

NYSE www.cencora.com


$ 241.14 $ 1.36 (0.57 %)    

Monday, 16-Sep-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.20 (-0.46 %)
DIA $ 417.33 $ 2.39 (0.58 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 241.24
$ 242.41
$ 241.36 x 100
-- x --
$ 240.97 - $ 243.72
$ 175.38 - $ 247.13
1,153,002
na
47.54B
$ 0.62
$ 25.61
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-you-would-have-made-owning-cencora-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
09/09/2024 20:30:18

deep-dive-into-cencora-stock-analyst-perspectives-6-ratings
Deep Dive Into Cencora Stock: Analyst Pers...
09/06/2024 13:00:57

baird-maintains-outperform-on-cencora-lowers-price-target-to-283
Baird Maintains Outperform on Cencora, Low...
09/06/2024 11:07:10

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and lowers the price target from $287 to $283.

opioid-settlement-drug-distributors-mckesson-cencora-cardinal-health-to-pay-300m-to-health-insurers
Opioid Settlement: Drug Distributors McKes...
09/03/2024 19:14:34

Three major U.S. drug distributors, McKesson, Cencora, and Cardinal Health, have agreed to a $300 million settlement over claim...

1000-invested-in-cencora-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Cencora 5 Years Ago Woul...
08/28/2024 20:00:48

Core News & Articles
Watching Cencora; Traders Circulate Unconf...
08/26/2024 15:00:18

deep-dive-into-cencora-stock-analyst-perspectives-5-ratings
Deep Dive Into Cencora Stock: Analyst Pers...
08/21/2024 15:00:27

jp-morgan-maintains-overweight-on-cencora-raises-price-target-to-287
JP Morgan Maintains Overweight on Cencora,...
08/21/2024 14:08:22

JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $280 to $287.

peering-into-cencoras-recent-short-interest
Peering Into Cencora's Recent Short Interest
08/14/2024 14:30:14

heres-how-much-you-would-have-made-owning-cencora-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
08/02/2024 14:00:39

Core News & Articles
Cencora Announces $250M Common Share Repur...
08/01/2024 22:23:06

Cencora, Inc. (NYSE:COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Allia...

Core News & Articles
Walgreens Boots Alliance Sells All Remain...
08/01/2024 22:22:38

Transaction HighlightsWalgreens Boots Alliance announces sale of all remaining unencumbered shares of Cencora, Inc. for proceed...

wells-fargo-maintains-equal-weight-on-cencora-raises-price-target-to-249
Wells Fargo Maintains Equal-Weight on Cenc...
08/01/2024 13:43:31

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Equal-Weight and raises the price target from $236 to...

baird-maintains-outperform-on-cencora-raises-price-target-to-287
Baird Maintains Outperform on Cencora, Rai...
08/01/2024 11:54:12

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $285 to $287.

cencora-forecasts-2024-adjusted-eps-of-1355-1365-versus-prior-guidance-of-1335-1355-and-consensus-of-1347
Cencora Forecasts 2024 Adjusted EPS Of $13...
07/31/2024 10:34:39

cencora-q3-2024-adjusted-eps-334-beats-410-estimate-sales-7424b-beat-7305b-estimate
Cencora Q3 2024 Adjusted EPS $3.34 Beats $...
07/31/2024 10:33:08

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-300-today
If You Invested $100 In This Stock 5 Years...
07/17/2024 20:00:21

abbvie-appeals-to-supreme-court-over-attorney-client-privilege-in-long-standing-androgel-case
AbbVie Appeals To Supreme Court Over Attor...
07/12/2024 17:39:05

AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-clien...

if-you-invested-100-in-this-stock-5-years-ago-you-would-have-200-today
If You Invested $100 In This Stock 5 Years...
07/09/2024 18:30:34

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION